Evaluation Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: Together with chemotherapy, for your cure of adult sufferers with locally recurrent unresectable or metastatic triple-damaging breast cancer who definitely have not received prior chemotherapy for metastatic ailment